Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Board/Management Information 2012

May 2, 2012

29777_rns_2012-05-02_435ae95b-59f9-427f-9526-67d5a0b6e6a1.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 a12-10878_28k.htm 8-K

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*

*WASHINGTON, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): April 27, 2012

*Abbott Laboratories*

(Exact name of registrant as specified in its charter)

Illinois 1-2189 36-0698440
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)

*100 Abbott Park Road*

*Abbott Park, Illinois 60064-6400*

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (847) 937-6100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901037\12-10878-2\task5318298\10878-2-ba.htm',USER='C901037',CD='May 2 06:49 2012'

*Item 5.02 Departure of Directors or Certain Officers.*

Edward L. Michael, Executive Vice President, Diagnostics Products, has informed Abbott that he will be retiring from the company within the next couple of months.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901037\12-10878-2\task5318298\10878-2-ba.htm',USER='C901037',CD='May 2 06:49 2012'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Thomas C. Freyman
Thomas C. Freyman
Executive Vice President, Finance and Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901037\12-10878-2\task5318298\10878-2-ba.htm',USER='C901037',CD='May 2 06:49 2012'